BioSpace
63
Signal
BI
BioSpace
biospace.comAIbiospace.com
BioSpace has a live public website and enough signal for an early FounderDeck profile.
FounderDeck estimate
$360k
Valued 2026-09-02
Gaining Momentum 0 portfolios
BioSpace
BioSpace has a live public website and enough signal for an early FounderDeck profile.
biospace.comGaining MomentumUnclaimed ProfileAI NativeBoring but ProfitableFeatured
FounderDeck estimate
$360k
Low confidenceValued Sep 2, 2026
0
Portfolios
Browse companies freely. New portfolio additions come exclusively from your daily pack.
MarketplaceLive product
0
Momentum
0
Daily views
0
Pack saves
Momentum rises when people search, view, like, share, claim, or save this profile.
What it does
BioSpace: Biotech, Pharmaceutical and Clinical Research News News Drug Development FDA Manufacturing Deals Business Job Trends Cell and Gene Therapy Cancer Opinions Press Releases All News & Releases Podcasts Events Jobs FounderDeck captured this company from its public website and generated an early discovery profile from the product signals visible on the page.
Who it helps
Likely aimed at teams or operators using AI to automate workflows, speed up output, or unlock a new capability.
Why it's interesting
BioSpace shows a live product footprint, a visible market angle, and enough public signal to be worth tracking early on FounderDeck.
Profile signals
Signal Score63
Product Clarity58
Founder Momentum58
Market Potential62
Website Polish71
Monetisation70
Shareability54
Buzz73
AI-assisted scores estimated from public website information only.
FounderDeck estimate
Low confidence$360k
FounderDeck estimated this early value from the public website, product clarity, market shape, monetisation cues, and overall signal strength visible on the page.
Valuation date: 2026-09-02. Estimate generated from public signals.
Portfolio saves
Added to 0 portfolios.
Portfolio saves do not represent ownership, equity, investment rights, IP rights, or affiliation.
Estimates are AI-generated from public information and are not financial advice or verified company valuations.